KEY TAKEAWAYS FROM THE SPRING 2021 LIFE SCIENCES INDUSTRY OUTLOOK
- As the pandemic evolves to become an endemic part of life, life sciences companies, along with other businesses, must consider new technologies, business models and consumer preferences.
- Strong capital markets continue to propel growth in the industry, while public markets reflect long-term growth opportunities.
- The Federal Trade Commission has voiced a more skeptical tone toward life sciences mergers.
- Over the last several months, the pharmaceutical industry has seen an improvement in public perception
Read the complete Life Sciences Industry Outlook report here.